Key result
SEMMELWEIS-CRT score predicts 5-year post-implant mortality, identifying patients with ~6.7-fold higher risk.
Why the study?
The study aimed to develop a machine learning-based risk stratification system to predict 1- to 5-year all-cause mortality using pre-implant parameters in patients undergoing CRT.
Does the machine learning-based SEMMELWEIS-CRT score improve the prediction of 1- to 5-year all-cause mortality compared to pre-existing risk scores in patients undergoing cardiac resynchronization therapy?
Cohort (n=1,668)
No
Does the machine learning-based SEMMELWEIS-CRT score improve the prediction of 1- to 5-year all-cause mortality compared to pre-existing risk scores in patients undergoing cardiac resynchronization therapy?
The machine learning-based SEMMELWEIS-CRT score provides superior individualized 1- to 5-year mortality risk stratification for patients undergoing CRT implantation compared with existing conventional risk scores.
Answers are grounded in this paper and cite their sources.
May refine CRT risk stratification; extends prior scores but requires prospective validation before practice change.
AIMS: Our aim was to develop a machine learning (ML)-based risk stratification system to predict 1-, 2-, 3-, 4-, and 5-year all-cause mortality from pre-implant parameters of patients undergoing cardiac resynchronization therapy (CRT). METHODS AND RESULTS: Multiple ML models were trained on a retrospective database of 1510 patients undergoing CRT implantation to predict 1- to 5-year all-cause mortality. Thirty-three pre-implant clinical features were selected to train the models. The best performing model [SEMMELWEIS-CRT score (perSonalizEd assessMent of estiMatEd risk of mortaLity With machinE learnIng in patientS undergoing CRT implantation)], along with pre-existing scores (Seattle Heart Failure Model, VALID-CRT, EAARN, ScREEN, and CRT-score), was tested on an independent cohort of 158 patients. There were 805 (53%) deaths in the training cohort and 80 (51%) deaths in the test cohort during the 5-year follow-up period. Among the trained classifiers, random forest demonstrated the best performance. For the prediction of 1-, 2-, 3-, 4-, and 5-year mortality, the areas under the receiver operating characteristic curves of the SEMMELWEIS-CRT score were 0.768 (95% CI: 0.674-0.861; P < 0.001), 0.793 (95% CI: 0.718-0.867; P < 0.001), 0.785 (95% CI: 0.711-0.859; P < 0.001), 0.776 (95% CI: 0.703-0.849; P < 0.001), and 0.803 (95% CI: 0.733-0.872; P < 0.001), respectively. The discriminative ability of our model was superior to other evaluated scores. CONCLUSION: The SEMMELWEIS-CRT score (available at semmelweiscrtscore.com) exhibited good discriminative capabilities for the prediction of all-cause death in CRT patients and outperformed the already existing risk scores. By capturing the non-linear association of predictors, the utilization of ML approaches may facilitate optimal candidate selection and prognostication of patients undergoing CRT implantation.
No takes yet. Share an insight, caveat, or question.
Tokodi et al. (2019) conducted a cohort in Symptomatic heart failure with reduced ejection fraction and wide QRS complex undergoing cardiac resynchronization therapy (CRT) (n=1,668). SEMMELWEIS-CRT score (Random Forest machine learning model using 33 pre-implant clinical variables) vs. Pre-existing CRT risk scores (Seattle Heart Failure Model, VALID-CRT, EAARN, ScREEN, and CRT-score) and lowest predicted risk quartile (1st quartile) was evaluated on 5-year all-cause mortality (HR 6.71, 95% CI 3.17-14.21, p=<0.001). The machine learning-based SEMMELWEIS-CRT score accurately predicted 1- to 5-year all-cause mortality in CRT patients (5-year AUC 0.803, 95% CI 0.733-0.872; P<0.001), outperforming existing risk scores.
Synapse has enriched 10 related papers. Consider them for comparative context: